Diego Herrera

Head of Clinical Data & Information Management | Almirall Sant Feliu, Spain
Diego Herrera


Diego Herrera, B.Sc Life Science graduated at Barcelona Central University, specialized in Laboratory of Hematology and Biochemistry Analysis. He currently occupies the position of Head in Clinical Data and Information Management in Almirall R&D (Spain). His over 30 years professional evolution has been developed in different positions and now leading clinical technology projects for digital transformation of clinical trials


Parallel Session | IOT Solutions World Congress

Improving clinical endpoints with AI for quicker and more reliable clinical trials

Taig Mac Carthy
Taig Mac Carthy Legit.Health COO & Co founder of Legit.Health Speaker
Diego Herrera
Diego Herrera Almirall Head of Clinical Data & Information Management Speaker

#AI, #Healthcare, #Remote Health Monitoring

02-02-2023 14:15 02-02-2023 14:45 Europe/Madrid Improving clinical endpoints with AI for quicker and more reliable clinical trials

Clinical trials are the way in which pharmaceutical companies ensure patients safety and measure the effectiveness of the treatment. In the last three years there has been a rise in decentralized clinical trials (DET). In this presentation the clinical artificial intelligence company Legit.Health reveals the work they have done along side the pharmaceutical company Almirall. By using computer vision during clinical trials they have uncovered a window into the future of clinical trials, with higher probability and lower costs.

Room 4
Thu 2 14:15h - 14:45h Room 4

Pedro Mier

Pedro Mier holds a degree in Telecommunications Engineer ing from the Polytechnic University of Catalonia, MBA from ESADE and PADE from IESE. He is currently President of AMETIC (Association of Electronics, Information Technology and Telecommunications Companies of Spain), Shareholder and Chairman of the Board of Directors of TRYO Aerospace & Electronics, Board Member of the Premo Group and Committee of CTTC. member of Space Angels Network and Member of the Sc ientific Advisory